+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Atomoxetine"

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
From
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Atomoxetine is a drug used to treat attention-deficit/hyperactivity disorder (ADHD) and other mental disorders. It is a selective norepinephrine reuptake inhibitor (SNRI) that works by increasing the amount of norepinephrine in the brain, which helps to improve focus and reduce impulsivity. Atomoxetine is available in both immediate-release and extended-release formulations, and is usually taken once or twice a day. It is generally well-tolerated, with the most common side effects being nausea, decreased appetite, and insomnia. Atomoxetine is one of the most commonly prescribed medications for ADHD, and is also used to treat other mental disorders such as depression, anxiety, and obsessive-compulsive disorder. It is available in generic form, as well as under the brand names Strattera and Tomoxetin. The Atomoxetine market is highly competitive, with several major pharmaceutical companies producing and marketing the drug. These include Eli Lilly, Pfizer, Shire, and Teva Pharmaceuticals. Show Less Read more